In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
about
Nanoparticulate carriers for the treatment of coronary restenosisProtein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vectorGene Delivery by Subconjunctival Injection of Adenovirus in Rats: A Study of Local Distribution, Transgene Duration and SafetyAdenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivoVariability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organsReactive oxygen species are downstream mediators of p53-dependent apoptosisLocal gene delivery to the vessel wall.Restenosis and gene therapy.Spine fusion by gene therapy.Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia.Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response.rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation.Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteriesEstablished immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity.Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo.Protection from reoxygenation injury by inhibition of rac1.A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy.Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury.Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.Viral vectors for vascular gene therapyInhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2.Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.Ganciclovir and penciclovir, but not acyclovir, induce apoptosis in herpes simplex virus thymidine kinase-transformed baby hamster kidney cells.Gene therapy for cerebrovascular disease.Rac1 is required for cell proliferation and G2/M progression.In vivo gene transfer: a biological tool.Ambient but not incremental oxidant generation effects intercellular adhesion molecule 1 induction by tumour necrosis factor alpha in endothelium.Design of a muscle cell-specific expression vector utilising human vascular smooth muscle alpha-actin regulatory elements.Localized adenovirus gene delivery using antiviral IgG complexation.Adhesion of flowing monocytes to hypoxia-reoxygenation-exposed endothelial cells: role of Rac1, ROS, and VCAM-1.Transcellular transfer of active HSV-1 thymidine kinase mediated by an 11-amino-acid peptide from HIV-1 Tat.Adenovirus-mediated delivery of the Gax transcription factor to rat carotid arteries inhibits smooth muscle proliferation and induces apoptosis.Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries.New prospects for cardiovascular gene therapy.Expression of Id1 results in apoptosis of cardiac myocytes through a redox-dependent mechanism.
P2860
Q28220309-D718A8A5-9672-4246-8494-0F69EA203122Q28343705-BB930D17-6B7D-4A16-B863-9C382341EE52Q28551360-9D71BC61-909F-4C85-9B79-AD535006416CQ33650305-7AB168BA-A838-4B47-889E-276F6ADBD30EQ33817535-777B75C6-965A-4133-A89A-4A4DE4497018Q34403292-30E096C6-21E3-45EA-A360-106FAA14F4B6Q34418987-713FB76F-27F3-4D31-97D2-D1DCAA633D29Q34452138-8D0481F7-A399-4B57-B3ED-21BDCC947A3EQ35629546-041389D5-DA99-437E-AE66-EE12104A5A2AQ35766125-86FD5CEA-B7B3-4783-B0F1-304D14F3DA30Q35769081-2F2633EC-5F9F-4F02-A64D-527387013BE0Q35801091-29F94874-AFE1-49DC-8F87-84F0BEEDB9F8Q36564448-C5ACFC9D-1329-41F4-9492-CEE670D5CD65Q37357232-E971651B-97AC-42D9-A70D-6FBCE1D4698CQ37362429-AE3B78B6-0B0B-468A-AB43-A1188C80696BQ37371503-97E73AC6-2555-48ED-B912-DDAEEB48A986Q37381258-1BE11C97-A210-4D1A-ABB6-C9153507A0CFQ37384785-9EB3AD47-EBDB-48BD-88CE-CB4F633B709CQ37448919-ECC2920B-7BDC-4171-BFB7-5F7BA4529716Q37511128-3AB38AFA-88DE-4684-B6C8-25AD7DFADE47Q37569631-730086C4-4477-4857-8EBE-E1F8AD572C6DQ39795032-4DC1314D-E00C-4CE2-A7F2-FAC8147934FDQ39882081-35D28586-1B04-466E-A397-00DCC010DF04Q40637172-AC7941AE-3979-40C4-A9F0-1612214B7496Q40825648-4A4DA803-9891-4FEF-811E-FAB04E45A4BDQ41093720-4AC884C7-F82B-40BC-A1EC-8EEE4B6EB50EQ41500672-8F365A91-E031-498B-8DA1-2C97A094DAB7Q42241749-D24A9ED8-1412-4258-957C-C7070E0B6FF3Q42477185-FF7A3EE8-B824-444F-B0DB-EC682DADB2DAQ43640507-ADA24E42-125E-4824-BAF6-8F31E4AB5694Q44021400-C555C8FD-C87C-40E5-A3A1-BB929B775ACFQ44253862-737F7336-743A-4B52-9FA1-BE1C3DBE77F4Q45862520-73DB8A70-F5F9-424D-822B-3B2BC44951DCQ45870659-A078AA61-99C1-41D4-8A65-D626D7593E58Q45884606-929DD214-B7B0-4B47-9B6F-5E113453FF04Q52184251-30079CA3-6D67-427D-8164-3FD390FE7887
P2860
In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
In vivo suppression of injury- ...... x virus thymidine kinase gene.
@ast
In vivo suppression of injury- ...... x virus thymidine kinase gene.
@en
type
label
In vivo suppression of injury- ...... x virus thymidine kinase gene.
@ast
In vivo suppression of injury- ...... x virus thymidine kinase gene.
@en
prefLabel
In vivo suppression of injury- ...... x virus thymidine kinase gene.
@ast
In vivo suppression of injury- ...... x virus thymidine kinase gene.
@en
P2093
P2860
P356
P1476
In vivo suppression of injury- ...... x virus thymidine kinase gene.
@en
P2093
Crystal RG
Epstein SE
Hirschowitz EA
P2860
P304
10732-10736
P356
10.1073/PNAS.91.22.10732
P407
P577
1994-10-01T00:00:00Z